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The objective of this project was to further characterize 
the compound(s) from Datura stramonium leaves responsible 
for antiviral activity. A variety of protein purification 
techniques were explored in the isolation of the active 
material. The purification steps finally established as 
useful were (in this order) : 60-80% eunmonium sulfate 
precipitation, dialysis, heat^treatment at 60*C, and 
chromatography on DEAE-ce 1 lu lose followed by Sephadex G-200. 
The first peak eluted (following the void volume peak) from 
the G-200 column contained the majority of the antiviral 
activity. This peak was further characterized by SDS-PAGE, 
tested for RNase activity, and digested with trypsin. All 
antiviral fractions contained a protein of -17,000 MW and 
the antiviral activity was destroyed by trypsin. The 
initial fractions from this peak also contained PKase 
activity, while the remainder of the fractions were only 
antiviral. The heat-treated extract was also fractionated 
using centrifugal filters having lOOK, 30K, and lOK 
molecular weight cut-offs. These fractions were 
characterized by SDS-PAGE, and tested for antiviral and 
RNase activity. The +10,000 (10,000-30,000 MW), +30,000 
(30,000-100,000 MW), and +100,000 (above 100,000 MW) 
molecular weight fractions were antiviral, while only the 
+30,000 and +100,000 fractions showed RNase activity. Data 
suggest the antiviral material is present as a -87,000 MW 
complex which is not precipitated by heat. The data suggest 
the antiviral complex is composed of proteins of -17,000 MW 
and -12,000 MW, an antiviral protein of unknown size, and an 
RNase-active protein. Future studies of the material 
present in the complex should help to elucidate the nature 
of the components present.
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INTRODUCTION
The use of plants to treat disease has been a common 
practice since the beginning of history. Natural medicinaIs 
have been used to treat diseases from cancer to warts with 
varying degrees of success. Some of these (such as quinine, 
opium, and digitalis) have found their place in modern 
medicine. The CRC Handbook of Medicinal Herbs lists 365 
plants of medicinal use world<^wide and the Medicinal Plants 
Of the Mountain West contains references to 120 medicinal 
plants found in our geographic area. This number of plants 
represents only a small fraction of the 265,000 different 
species of plants which are available for study and testing.
It stands to reason that of these many plants a 
percentage of them would have antiviral (viricidal or 
virustatic) components. Upon testing this turns out to be 
the case (1,8,22,25).
The discovery of Pokeweed Antiviral Protein (PAP) in 
1925 signalled the beginning of a new area of research, 
plant antiviraIs. Sap from pokeweed reduced the infectivity 
of TMV when mixed together and inoculated onto a TMV- 
susceptible host. This sap was further purified and a 
protein was isolated which would inhibit TMV and a variety 
of other viruses from plants and animals (8). The discovery 
of PAP led to research into other plants, and eventually 
this led to the discovery of many other antiviral compounds 
from plants. Further testing would show that these
antivirals functioned by a number of different mechanisms.
Plant compounds function in a wide variety of ways to 
achieve their antiviral effect. Photosensitizers function 
in concert with ultraviolet light to cause damage to viral 
nucleic acids# % i s  damage is accomplished by one or more 
of the following: DNA/protein cross-linking, guanine 
oxidation, or singlet oxygen production (8). Terpenoids 
function as antivirals at the level of the membrane, either 
by interference with the adsorption/penetration of the virus 
or at the time of assembly and/or release (8). Lignans 
affect viruses at some early step of their infection, while 
phenolic compounds appear to function at various key steps 
during the virus life cycle (8) . Proteins and peptides have 
activities ranging from interference with early steps of the 
virus infection to exerting their effects at the level of 
protein synthesis <8).
Antiviral Proteins from Plants
Induced Antiviral Proteins
The induced antiviral proteins (lAVPs) are produced as 
a result of a viral infection, and therefore are not always 
present (3-7)• These proteins can exert their effect at a 
distance from the site of infection, and upon viral 
challenge show marked inhibition. Examples of these 
proteins are antiviral factor (AVF) extracted from tobacco 
mosaic virus infected leaves of Nlcotlana glutlnosa,' 
inhibitor of virus replication <IVR) found in the culture
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supernatant of TMV-infected tobacco protoplasts, and 
antiviral substance (AVS) which is also found in the culture 
medium of infected tobacco protoplasts (7,8,25).
Sela and Applebaum were the first to describe the 
production of a substance in virus-infected plants which 
when isolated would protect new plants from infection (26). 
Sap from infected leaves was found to inhibit local lesion 
production when mixed with virus and inoculated onto healthy 
leaves. The sap from uninfected leaves was found to be non- 
inhibitory. They postulated that the inhibitory substance 
was being produced as a result of virus infection and 
suggested that its activity might be similar to the action 
of interferon observed in animal tissues (26). Further work 
showed that AVF was present in infected tissue, and could be 
isolated using methods similar to those used for the 
isolation of interferon from human leukocytes (25). Further 
work by Sela demonstrated that AVF was present in minute 
G[uantities in uninfected tissues, and that virus infection 
was directly responsible for the production of AVF in larger 
quantities (25).
Gera et al. showed that infection of protoplasts from a 
hypersensitive strain of tobacco with TMV caused the release 
of an inhibitory substance into the protoplast culture 
medium (5,25). This substance, inhibitor of virus 
replication (IVR), was found to inhibit virus replication in 
protoplasts isolated from both hypersensitive and systemic
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responding varieties of Sainsun tobacco* IVR was found to be 
inhibitory when applied up to 18 hours after infection with 
TMV (5,7)*
Mitra isolated two antiviral substances (AVS) from the 
tissue culture medium of TMV infected protoplasts (AVS-30 
and AVS-65) (25) • AVS-30 was found in the medium of both 
infected and uninfected protoplasts and was believed to be 
present as an endogenous inhibitor, whereas AVS-65 was 
produced as a response to TMV infection. AVS-65 was able to 
transfer resistance to TMV infection to protoplasts in a 
manner reminiscent of interferon action (25)•
Endogenous Antiviral Proteins
Endogenous antiviral proteins (EAVPs), in contrast, are 
always present within the plant* These proteins did not 
appear to exert their antiviral activity within the source 
plant from which they were extracted, because no obvious 
protection was observed. However, these proteins were 
antiviral in other plant species upon external or mechanical 
inoculation (8-11) under laboratory conditions, and were 
termed 'altruistic'* Further research with Pokeweed 
antiviral protein (PAP) has shown that this 'altruistic' 
effect may not be the case (25)*
The EAVPs can be classified into three general
categories based upon their mode of action: proteins that
inhibit or inactivate eukaryotic ribosomes, proteins that
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induce an antiviral response, and proteins that prevent the 
establishment of a viral infection by some mechanism other 
than those just described.
Pokeweed antiviral protein (Phytolacca, amerlcana) , 
Gelonin (Gelonlum mjltiflorum), and Dianthin (Dianthus 
caxyophyllus)are included in the category of ribosomal 
inhibitory proteins (HIPs). RIPs are capable of 
inactivating the large 60S subunit of eukaryotic ribosomes 
and the antiviral effect(s) may be dependent upon this 
inactivation (8,9,13,14)• The mechanism of inhibition 
exhibited by PAP has been shown to be catalytic in nature, 
implying that virus replication may be prevented as a result 
of interference with the host ribosomes ability to bind 
elongation factors (14)• The inhibitor, entering the cell 
during mechanical inoculation along with infective viral 
RNA, inactivates the 60S subunit of the ribosome and 
consequently stops viral multiplication. This results in an 
aborted viral infection (14). When PAP was tested against 
herpes simplex and poliovirus In vitro, it was found that 
the activity was dependent upon the interaction of the virus 
with the cellular membrane. This interaction facilitated 
the entry of PAP into the cell with subsequent inactivation 
of the host cell ribosomes and cessation of protein 
synthesis (8,15).
The mechaniem by which ribosomee are inactivated ih 
vivo is thought to be due to the N-glycosidase activity of
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RIPs. This activity breaks the W-glycosidic bond at 
adenine*^^ in the 28S rRNA which allows cleavage of the RNA 
by aniline in vitro. This cleavage is responsible for the 
inability of ribosomes to bind elongation factors (EFl and 
EF2) and the resultant inhibition of protein synthesis (14)•
The second mode of action is by the induction of a 
systemic antiviral response (systemic resistance)• The 
treatment of one portion of the plant results in either the 
entire plant mounting an antiviral response (Boerhmavia 
diffusa)(16,17), or a response which is restricted locally 
to the treated leaf (Chenopodium ambrosoides) (18) . The 
action of the inhibitor may be attributed to the blockage of 
the host cell receptor or to interference with virus 
synthesis within the host cell. The actual mechanism by 
which the inhibition occurs has not been elucidated.
Proteins which prevent the establishment of a viral 
infection fall into the last category. The antiviral effect 
is of a localized nature, causing the inhibition of virus in 
treated areas only. Extracts of Datura have been shown to 
cause this type of resistance (11) as well as extracts from 
other solanaceous plants (21) and various plant lectins (8).
It was previously thought that Datura stramonium 
extract inhibited the establishment of virus in a localized 
reaction by competing for available receptors (10,11,19,20). 
However, other studies found no evidence of virus-specific 
receptors on the plasma membrane surface (31). This
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evidence suggests that interference with the virus may occur 
at a different stage in the infection.
It is possible that this interference is due to 
degradation of the infective nucleic acids. Research by 
Saxena and colleagues shows that ricin (antiviral protein 
from Riclnas communis) will abolish protein synthesis in 
Xenopus oocytes when either injected or added to the oocyte 
incubation medium. The RNA glycosylase activity of ricin 
removes a single base adjacent to the alpha sarcin site from 
the 28 S RNA in Xsnopus oocytes (28) • Therefore, it is 
possible that the antiviral activity observed with other 
plant antiviral proteins could be a result of RNase*like 
activity.
Datura stramonium has been used for centuries 
throughout the world for the treatment of cancers, tumors 
and indurations. In China it is used as a treatment for 
flatulence, hyperacidity, and tuberculosis sweats; in Mexico 
for birthing pains; in Costa Rica for tumors and ulcers; and 
in Africa (by the Arabs) for the treatment of influenza and 
asthma (1). In the United States, this plant (leaves) was 
used for the treatment of asthma, as an analgesic and anti­
inflammatory, and also as a hallucinogen in Native American 
religious ceremonies (2) • The widespread use of this plant 
as a medicinal suggests that this plant may contain 
compounds which could be used therapeutically, some of which 
may prove to be antiviral.
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Previous studies have shown that extracts of Datura 
contain an endogenous inhibitor that when mixed with virus 
and inoculated onto a permissive host exerts an antiviral 
effect (9,10,11). Apablaza and Bernier showed that an 
extract from Datura leaves was inhibitory against TMV when 
tested in a pinto bean local lesion assay. This activity 
was heat-labile (100*C for 10 minutes) and was retained by a
50,000 MW cutoff filter (10). Grasso and Shepherd found 
that upon purification by ion-exchange chromatography, an 
inhibitor from Datura gave an intense double band of 17,000 
MW when visualized by SDS-PAGE (9). Using a partially 
purified extract of Datura, Zipf determined that the 
inhibitory activity was pH stable (pH 3-10) and was not 
reduced upon treatment with papain, acid phosphatase, formic 
acid, cysteine, or performic acid. The inhibitory activity 
was not affected by heating at 65*C-70’C for 10 minutes. 
Antiviral activity was reduced upon treatment with trypsin 
(10%), acetic anhydride (50%), and phenyl isocyanate (70%) 
(11) .
Purpose of study
The purpose of this study was to further characterize 
the antiviral compound(s) from Datura stramonium leaves.
The purification was accomplished by ammonium sulfate 
precipitation of leaf homogenate and chromatography on a 
DEAE-Cellulose column followed by a Sephadex G-200 column. 
This material was characterized by agarose and acrylamide
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gel electrophoresis, and molecular weight fractionation.
The antiviral activity was evaluated with a Pinto 
bean/Tobacco Mosaic Virus inhibition assay.
MATERIALS anS METHODS
Buffers: The buffer used throughout these experiments was a
0.067H sodium phosphate dibasic/potassium phosphate 
monobasic buffer at pH 6.0, pH 7.0, or pH 7.9. Buffer 
species were made as lOX solutions and stored at room 
temperature (16-22"C). For use, buffer species were diluted 
10-fold with H2O and mixed together until the desired pH was 
reached.
Growth of plants: The pinto bean plants (Phaseolus vulgaris 
var. Pinto) were grown in Peat Lite mix (Grace Sierra, Ca.) 
in a ten^perature-^controlled growth room in a greenhouse.
Two seeds were planted per 4” plastic pot and watered when 
the soil became dry (approximately every 2 days). Datura 
seeds were planted in plastic flats (24"xl2"x2") and grown 
to the 2-leaf stage after which they were transplanted to 
individual pots. All plants were grown in a 16 hr light/8 
hr dark photoperiod at 21*C to 27"C (70*F to 80*F) . Pinto 
beans were used at 9-11 days (primary leaf stage), and the 
Datura leaves were harvested at maturity and stored at -20*C 
until needed.
Protein content: The protein content of samples was
determined by the use of the Micro EGA Protein Assay Reagent 
Kit (Pierce, Rockford, II.) by either the tube or microplate
10
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method as described in the literature supplied with the kit. 
Readings were taken at for the tube method and at for 
the microplate method. Where specified, the Coomassie 
Brilliant Blue Protein Assay Reagent Kit (Pierce, Rockford,
II.) was used to assay for protein content. In all cases a 
standard curve was generated by diluting BSA (2 mg/ml) to 
known concentrations and assaying under the conditions 
dictated by the assay method. By comparing the absorbance 
of each fraction with the standard curve, a protein 
concentration for each unknown could be determined.
Purification and Titration of TMV: A stock solution of 
Tobacco Mosaic Virus (TMV) was prepared as follows: Frozen
(-20*0) tobacco leaves infected with TMV were homogenized 
1:1 in pH 7.0 buffer. This material was centrifuged at 3,473 
X g (3500 rpm) for 15 min at 4*0 in a Beckman TY JS-4.2 
rotor. The pooled supernatant was centrifuged through a 30% 
sucrose cushion at 111,000 x g (25,000 rpm) for 7 hours at 
4*0 in a Beckman SW-2Ô rotor. Pellets were resuspended in 2 
ml of HjO for each pellet and loaded on 10-40% sucrose 
gradients. These were centrifuged at 125,000 x g (26,000 
rpm) for 4 hours at 4*0 in a SW-28 rotor. The opaque band 
was harvested from the gradient, diluted with HgO, and 
centrifuged at 111,000 x g (25,000 rpm) for 3 hours at 4*0 
in a SW-28 rotor. The supernatant was discarded and the 
virus pellets resuspended in 3 ml of H^O per pellet. This
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TMV suspension was stored at -20'C in 0.5 ml aliquots until 
needed•
The virus stock was titrated by making serial 5-fold 
dilutions in buffer, mixing 1:1 with additional buffer, and 
adding Celite abrasive (15 mg/ml). The inoculation was 
performed by placing 200 /til of the mixture onto the half­
leaf and rubbing the half-leaf with a fingertip. The 
infected plants were grown for 7 days, the leaves harvested, 
and the lesions counted with the aid of a dissecting scope.
A lesion is defined as a necrotic spot on the leaf 
surface, red-brown to gray in color and circular with 
irregular edges. Lesions will in some cases be bounded by a 
light green area. The average number of lesions obtained 
throughout the year varied with the season. Control lesion 
numbers obtained in the spring and fall were usually higher 
than at other times of the year. This agrees with 
observations made by Zipf (11).
Preparation of the Datura extract: Frozen (-20*0) leaves of
Datura stramonium were homogenized 1:1 in cold (4*0) pH 7.0 
buffer in the presence of 0.1% 8-Mercaptoethano 1 with a 
Waring blendor. The resultant homogenate was placed in 250 
ml centrifuge bottles, and centrifuged at 18,200 x g (8000 
rpm> for 50 minutes at 4*0 in a GSA rotor. The pellets were 
discarded and the supernatants pooled before precipitation 
with ammonium sulfate.
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Protein precipitation was accomplished by a 60% to 80% 
ammonium sulfate  ̂cut^. This cut had been previously 
determined to contain the maximal antiviral activity from 
Datura. (11) • The pooled supernatant was brought to 60% of 
saturation by the addition of solid ammonium sulfate and the 
solution stirred overnight at 4*C. The fluid was placed 
into 250 ml centrifuge bottles and centrifuged at 18,200 x g 
(8000 rpm) for l hour at 4*C in a GSA rotor. The pellets 
were discarded and the supernatant brought to 80% of 
saturation with solid ammonium sulfate and stirred overnight 
at 4*C* The solution was centrifuged as above, the 
supernatant discarded, and the pellets resuspended in a 
total of 2 ml of pH 7.0 buffer per 40 ml of starting liquid. 
This material was dialyzed at 4*C for 17 hours against four 
2 liter changes of pH 7.0 buffer, with buffer changes after 
2, 4, and 12 hours (Spectra-por dialysis tubing 12-14,000 HW 
cutoff, Fisher). The dialyzed material was stored at -20 
in 1.2 ml aliquots until needed.
Inhibition Assay: Mine to eleven day-old Pinto bean
{PhaseoXils vulgaris var. '*Pinto**) plants were used as the 
assay host. The assay unit used throughout the experiments 
was the half-leaf. A half-leaf is defined as the leaf 
surface extending laterally from the central vein of the 
primary leaf to the margin.
Serial five-fold dilutions of TMV were made in buffer
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to a dilution previously determined to give 100 to 200 
lesions per half-leaf. The control virus dilution contained 
virus dilution 1:1 with buffer. Experimental samples 
contained virus dilution l:i with the sample to be tested. 
Celite abrasive was then added to a concentration of 15 mg 
per ml of mixture. Using a micropipettor, 200 fil of the 
well-mixed sample was placed onto the leaf surface and 
rubbed onto the entire half-leaf surface with a fingertip. 
The inoculated plants were grown in the green-house for 7 
days, the leaves harvested, and the lesions counted with the 
aid of a dissecting microscope.
Heat Treatment of Datura extract: zipf determined that the
thermal inactivation point of the antiviral material from 
Datura was between 65*0 and 70*0, but no protein data were 
included (11).
Two aliquots of Datura were thawed, and centrifuged at 
12,500 X  g (14-15,000 rpm) in the benchtop microcentrifuge 
for 30 seconds. The supernatants were transferred to new 
tubes. One tube was placed on ice and one tube heat-treated 
as follows: The tube was placed in the 60*0 water bath for
10 minutes and then cooled on ice for 5 minutes. The 
material was centrifuged for 4 minutes at 12,500 x g (14-
15,000 rpm) in a benchtop microcentrifuge at 4*0 and the 
supernatant transferred to a new tube. The two aliquots 
were tested for antiviral activity by making serial 10-fold
15
dilutions and testing as outlined above for the inhibition 
assay.
Molecular yiltretiom: One ml of heat-treated Datura extract 
was loaded onto a lOOKda Centricon (Amicon) filter and 
centrifuged at 920 x g <2750 rpm) in an SS-34 (Sorvall) 
rotor at 4*c for 1 hour* The retentate was saved and the 
filtrate was loaded onto a aOkDa filter and centrifuged for 
1  hour at 4715 X g (6250 rpm) at 4^0. The retentate was 
saved and the filtrate was loaded onto a lOKOa cutoff filter 
and centrifuged for 2 hours at 4715 x g (6250 rpm) at 4*c. 
All material was resuspended to starting volume ( 1  ml) with 
buffer to obtain four different samples: + 1 0 0 kDa (material 
retained hy the lOOK filter), +3 0 kOa (<1 0 0 K and >3OK),
+10kDa (<30K and >10K), and *lOkDa (O-lOK)* All samples 
were stored at 4 ’c until use.
column <^&romatography:
DEAE-Cellulose: DEAE-cellulose (Whatman dE-52) column
matrix was prepared as follows: One volume of DE-52 matrix
was added to 15 volumes of 0.5M hydrochloric acid in H2O, 
stirred^ and allowed to settle for 30 minutes. Fine 
particles were removed by decanting and the matrix was 
repeatedly washed with until the pH was above 4.0. The 
matrix was soaked in 15 volumes of 0.5H sodium hydroxide in 
H^O for 30 minutes and repeatedly washed in H2O until the pH
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was below 7.0. The DEAE^cellulose was then suspended in pH
7.9 buffer overnight at 4*C. The excess buffer was removed, 
and the resultant slurry poured into the column (Pharmacia, 
Upsala, Sweden) at 4*C. The column was equilibrated with 3 
column volumes of buffer. The final column bed volume was 
40 ml. Column dimensions: 1.5 cm diameter by 28 cm length.
CM^celZuJfOse : CM-cellulose (Whatman CM-52) column matrix
was prepared as follows: One volume of CM-52 matrix was
added to 15 volumes of 0.5M sodium hydroxide in 
stirred, and allowed to settle for 30 minutes. Fine 
particles were removed by decanting and the matrix was 
repeatedly washed with HgO until the pH was below 8.0. The 
matrix was soaked in 15 volumes of 0.5M hydrochloric acid in 
H^O for 30 minutes and repeatedly washed in H^O until the pH 
was above 7.0. The CM-cellulose was then suspended in pH
6.0 buffer containing 0.01% sodium azide and aged at 4*C for 
1  week before pouring. The excess buffer was removed, and 
the resultant slurry poured into the column at 4*C. The 
column was equilibrated with 3 column volumes of buffer.
The final column bed volume was 69 ml. Column dimensions:
1.6 cm diameter by 35 cm length.
SeoAadex G^200: Two grams of Sephadex G-200 (Pharmacia)
were mixed with two column volumes of pH 7.9 buffer, 
autoclaved for 15 minutes (121*C and 15 atm) , and allowed to
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cool to 4*C. Excess buffer was removed, the slurry poured 
into the column, and the column equilibrated with 3 column 
volumes of buffer at 4*C. The final column bed volume was 
60 ml* Column <limensions: 1.6 cm diameter by 35 cm length.
The column void volume was determined using 0.5 mg/ml Blue 
Dextran (average MW of 2,000,000).
Column chromatography of extract:
DEAE-^cellulosB : Six aliquots of Datura, extract were thawed
and centrifuged for 1 minute at 12,500 x g (14-15,000 rpm) 
at 4*C in a benchtop microcentrifuge to sediment any 
particulate material. The supernatants were transferred to 
new Eppendorf tubes and heated in a 60*0 water bath for 10 
minutes. The tubes were removed and cooled on ice for 5 
minutes, and centrifuged at 12,500 x g (14-15,000 rpm) in 
the benchtop microcentrifuge for 4 minutes to sediment any 
heat^aggregated material. The supernatants were pooled and 
brought up to 18.5 ml with pH 7.9 buffer. The material was 
loaded onto the DEAE-cellulose column and allowed to run 
into the bed. The walls of the column were washed with 12 
ml of pH 7.9 buffer, and the washes allowed to run into the 
bed. The head-space was filled with buffer, the buffer 
reservoir attached, and the fraction collector set to 
collect 120 drop fractions (5 ml/tube). Buffer (pH 7.9) was 
allowed to wash the column by gravity feed. Eluted 
fractions were monitored at until the absorbance had
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returned to background. The adsorbed material was eluted 
with a linear 0-1.4M sodium chloride gradient. Fractions 
were tested for antiviral activity. In further 
purifications, tubes containing the unadsorbed material were 
pooled and concentrated using a Centriprep-10 centrifugal 
filter (10,000 MW cut-off, Amicon).
CM-ceilulose; The concentrated wash-through peak (pH 7.9) 
from the DEAE-cellulose column was buffer-exchanged to pH
6.0 by the use of a Centriprep-10 centrifugal filter. This 
was accomplished by multiple resuspensions of the 
centrifugally concentrated material with buffer pH 6.0.
Final volume of buffer-exchanged material was 1.2 ml. This 
material was resuspended to the starting volume of 5.2 ml 
with buffer pH 6.0, and a 0.5 ml aliquot was removed for 
testing. The remainder of the material was diluted to 25 ml 
with buffer and loaded onto the CM-cellulose column. The 
head-space was filled, and the column washed with buffer pH
6.0 until the Ajgo had returned to background collecting 5 ml 
fractions. Adsorbed material was eluted with a linear 0-lM 
sodium chloride gradient until the A2@o had returned to 
background. All fractions were stored at 4*C for testing.
Spphadex G-200; The concentrated wash-through peak obtained 
from the DEAE-cellulose column was resuspended to 1 % of the 
G^200 bed volume with pH 7.9 buffer (final volume 0.6 ml).
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This material was loaded onto the G*200 column, and allowed 
to drain into the bed. The walls of the column were washed 
with 1 ml of pH 7.9 buffer, the head-space filled, and the 
buffer reservoir attached. The column was washed with 3 
column volumes of buffer, and 120 drop fractions (5 ml) were 
collected. The Ajgo readings were used to generate a column 
elution profile. Aliquots of each fraction were stored at 
4*C for testing, and the remainder was stored at -20*C until 
needed.
Sodium Dodecyl Sulfate-Polyacrylamide Gel Blectropboresis 
(SDB*PAGB) : Electrophoresis was carried out by the method
of Laemmli (27) in 12.5% polyacrylamide gels with a 4% 
polyacrylamide stacking gel under denaturing (SDS-PAGE) 
conditions•
Material which had previously proved to be too dilute 
to be visualized by SDS-PAGE was concentrated by TCA 
precipitation (31)• Briefly, one volume of sample was miked 
with four volumes of 5% trichloroacetic acid and incubated 
overnight at 4*C. The precipitated material was centrifuged 
out of solution in a benchtop microcentrifuge for 15 min at 
12,500 X g (14-15,000 rpm) and resuspended in a small volume 
(50 fil) of 2X Laemmli Sample Buffer for electrophoresis.
4X Tris-Giveine Electrophoresis Running Buffer: 28.8 grams
of glycine and 6  grams of Tris base were dissolved in 250 ml
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of HjO and diluted to a final volume of 500 ml with H2O. For 
use, 5 ml of 10% SOS was added to 125 ml of the 4X buffer 
and diluted to 500 ml (denaturing gel). Buffer is pH 8.3 
when diluted to a IX concentration.
4X Tris-HCl Buffer dH 8 . 8  fl.5M Tris^; 45.5 grams of Tris
base was dissolved in 100 ml of HjO, adjusted to pH 8 . 8  with 
IN HCl, and diluted to a final volume of 250 ml with HgO.
4X Tris-HCl Buffer PH 6 . 8  f0.5M Tris) : 6.05 grams of Tris
base was dissolved in 50 ml of HjO, adjusted to pH 6 . 8  with 
IN HCl, and diluted to a final volume of 100 ml with H^O.
2X Laemmlj^Samole Buffer: 1.52 grams of Tris base, 20 ml of
glycerol, 2 grams of Sodium Dodecyl Sulfate (SOS) , 2 ml of 
B-Mercaptoethanol, and 1 mg of Bromphenol Blue were 
dissolved in 40 ml of HjO, adjusted to pH 6 . 8  with IN HCl, 
and diluted to a final volume of 1 0 0  ml with HgO.
30% Acrvlamide/0.8% Bisacrvlamide Solution: 30 grams of
acrylamide and 0.8 grams of N,N'-methylene-bisacrylamide 
were dissolved in 40 ml of H^O and diluted to a final volume 
of 100 ml with HjO. stored in the dark at 4*C.
Preparation of an Electrophoresis Gel (SDS-PAGE) : The glass
plates and 1.5 mm spacers were cleaned with 95% ethanol
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before assembly. The assembled plates were placed in a bag 
and clamped vertically to a plexiglas stand for pouring.
The analytical gel was prepared as follows: 13 ml of HjO,
1 0  ml of 4X Tris^HCX pH 8 . 8  buffer, and 16.8 ml of the 
acrylamide solution were mixed and degassed with a vacuum 
pump. To this mixture, 400 Ml of 10% SDS, 100 Ml of 10% 
ammonium persulfate, and 20 Ml of TEMED were added, mixed 
well, and poured between the glass plates using a 1 0  ml 
syringe fitted with a 18 gauge needle. This mixture was 
then overlaid with 2-3 ml of H^O to exclude air and allowed 
to polymerize for 30 minutes. The stacking gel was prepared 
as follows: 1 1  ml of HjO, 5 ml of 4X Tris-HCl pH 6 .8 , and
2 . 6  ml of the acrylamide solution were mixed and degassed.
To this mixture, 200 Ml of 10% SDS, 60 Ml of 10% ammonium 
persulfate, and 20 Ml of TEMED were added. The water 
overlay on the analytical gel was removed and the well-mixed 
stacking gel solution was poured as above. A comb was 
inserted and the stacking gel allowed to polymerize for 30 
minutes. The gel sandwich was then removed from the bag, 
clamped in the electrophoresis apparatus, and the upper and 
lower buffer chambers filled with running buffer pH 8.3 
containing SDS. The comb was removed and the wells rinsed 
with running buffer before the samples were loaded.
SDS-PAGE I All samples were mixed 1:1 with 2 x Laemmli Sample 
Buffer, boiled for 5 minutes, centrifuged at 12,500 x g (14-
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15,000 rpm) for 10 seconds, and loaded onto the gels. The 
gels were electrophoresed at 1 2 0  V until the marker dye was 
through the stacking gel, and then turned up to 200 V and 
electrophoresed until the marker dye was 0.5 cm from the 
bottom of the gel. The dye front was marked with india ink 
before staining as desired.
Molecular weight markers used: Phosphorylase B (*97,400
MW), Bovine Serum Albumin (*68,000 MW), Ovalubumin (*46,000 
MW), Carbonic Anhydrase (*30,000 MW), and Cytochrome C 
(*12,300 MW).
SÈâisiBS:
Coomstssie Brilliant Blue Stain for Proteins: Coomassie
Brilliant Blue staining was accomplished by staining the gel 
in Coomassie stain (50% methanol/0.05% Coomassie Brilliant 
Blue R /10% glacial acetic acid/40% H2O) for 1.5 to 2 hours. 
The stain solution was removed and the gel destained (5% 
methanol/7% glacial acetic acid/8 8 % HjO) until the blue 
bands were visible against a clear background (27).
Silver Stainincr for Proteins: Silver staining of the gels
was accomplished by the method of Wray (28) • Each gel was 
fixed in 50% methanol for 30 min and then washed in 2 
changes of dH2 0  for 15 min each. The silver stain was 
prepared as follows: 2.3 ml of a 3.6% solution of sodium
hydroxide was mixed with 20.3 ml of H2O and 1.4 ml of 14.8M
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ammonium hydroxide was added. To this mixture, 4 ml of a 
2 0 % silver nitrate solution was added dropwise with constant 
stirring. An additional 72 ml of H2O was added to this 
solution. The gel was soaked in the stain solution for 15 
minutes, the stain removed, and the gel washed with 3  
changes of HjO for 5 min each. The gels were developed by 
soaking in developer solution prepared as follows: 2.5 ml
of 1% citric acid and 0.25 ml of 36-37% formaldehyde were 
brought up to 500 ml with H2O. The gels were soaked in this 
solution until the bands were of the desired intensity, and 
the developer removed. The developing was stopped by 
replacing the developer with 50% methanol. Protein bands 
are visible as gray^brown to black bands in a clear to 
yellow background.
Molecular weight determination:
Bv SDS-PAGEX Fractions of interest and marker proteins were 
subjected to SDS-PAGE to determine the denatured molecular 
weight of the protein(s) present in the fractions (see 
above) . After staining with silver, the migration of the 
marker proteins relative to the dye front was used to 
generate a calibration curve for the gel. The relative 
migration of unknown bands was compared to the calibration 
curve and the molecular weight calculated (29) .
Bv Sephadex G^200: The Sephadex G-200 column was calibrated
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by the use of the MW-GF-200 kit (Sigma, St. Louis, MO.)
This was accomplished by elution of proteins of a known 
molecular weight from the column. The marker proteins used 
werei 8 -Amylase (-200,000 MW), Alcohol Dehydrogenase 
(-150,000 MW), Bovine Serum Albumin (-66,000 MW), Carbonic 
Anhydrase (-29,000 MW), and Cytochrome C (-12,400 MW). Blue 
Dextran (-2,000,000 MW) was used to determine the void 
volume of the column. The elution volumes of these marker 
proteins were used to generate a calibration curve for the 
column. The elution volumes of the extract column fractions 
were compared to this curve and approximate native molecular 
weights were calculated for each fraction.
RHase Activity in Agarose Gels: The presence of RNase
activity was monitored by the following procedure : 25 ^1 of 
the sample was mixed with 25 nl of whole TMV and 48 /il of 
HgO, and incubated on ice for 30 minutes. To each tube, 2 
Ml of 10% SDS was added to disrupt the virus. Twenty /il of 
loading dye (50% Sucrose/0.5% SDS/ 0.25% Bromphenol 
blue/H2 0 ) was added to each 100 /il reaction mix. Forty /il 
to 60 Ml of each sample was loaded onto a 1 % agarose gel (1 % 
agarose/ix TA£/1%SDS) and electrophoresed at 100 v to 
completion. The gels were washed in H^O for 1 hour to 
remove the SDS, stained with ethidium bromide (20 Ml of a 1  
mg/ml ethidium bromide solution per 1 0 0  ml of H^O) for 1  
hour, and destained with H^O. The gel was viewed with the
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aid of a UV transilluminator. RNase activity was indicated 
by the degradation of the TMV RNA band to fragments of a 
lesser size and a concomitant loss of fluorescence in the 
degraded RNA as compared to the control.
SOX TAB stock: 24.2 grams of Tris base, 5.71 ml of glacial 
acetic acid, and 10 ml of 0.5M EDTA pH 8.0 were added to 40 
ml of H2O and diluted to 1 0 0  ml with H^O.
Running Buffer: 10 ml of 50X TAE and 5 ml of 10% SDS were
diluted to 500 ml with H Ô.
1% Agarose gel: 0.5 grams of electrophoretic grade agarose
was added to 50 ml of HgO, and microwaved on high until the 
agarose was dissolved (45-60 seconds). One ml of 50X TAE 
and 0.5 ml of 1 0 % SDS were added, swirled to mix, and 
poured. The gel was allowed to cool and solidify before 
use.
Inhibition of RNase Activity: Twenty-five fil of each column
fraction (4-11) were treated by the addition of 2 /xl of 
either RNasin or 0.5M EDTA. After 30 minutes on ice, the 
virus was added and incubated for an additional 30 minutes. 
Two jul of 10% SDS and 20 fil loading dye were added to each. 
The samples were loaded onto a 1% agarose gel, and 
electrophoresed as above. If RNase was inhibited, the band
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corresponding to the virus RNA would not be degraded to 
smaller fragments.
Protease Treatment of Column Fractions: Two 600 /il aliquots
of each G-200 column fraction were thawed for use in this 
assay. Twenty mg of trypsin conjugated to acrylic beads 
(Sigma, St. Louis, MO) was added to each tube of one set of 
G-200 Column fractions, and the second set of tubes were not 
treated. Buffer pH 7.9 was also treated with enzyme to 
serve as a enzyme control, or untreated to serve as a 
temperature control. All samples were mixed well and 
incubated at 37*0 for 24 hours with shaking. The tubes were 
removed from the water bath, and centrifuged at 12,500 x g 
(14-15,000 rpm) to pellet the beads or any heat-pfecipitated 
material. The supernatants were removed to new tubes and 
tested for activity in the inhibitor assay. If the 
antiviral activity was sensitive to protease treatment, a 
reduction in antiviral activity would be observed by an 
increase in lesion number compared to untreated column 
fraction controls.
RESULTS
Titration of TMV
Serial 5-fold dilutions of the purified virus were made 
in buffer ranging from 1:5 to 1:78,125. The dilutions of 
1:125 to 1:78/125 were inoculated onto pinto bean half­
leaves as previously described. The dilution of 1:3125 gave
236.6 ± 53 lesions per half-leaf (Table l). For our assay 
system, an average of 1 0 0 - 2 0 0  lesions per half-leaf is 
optimal. This dilution falls on the linear portion of the 
titration curve and was used as the standard virus dilution 
in subsec[uent experiments.
Heat treatment of Datura extract
Serial 10-fold dilutions of the heated and unheated 
Datura extract were made to 10*̂ , and the dilutions of 10^ to 
10"̂  were tested for activity by the inhibition assay. This 
experiment was performed in duplicate on two separate days. 
These data showed that the heated extract was slightly more 
inhibitory than the unheated material in both experiments. 
The average IC5 0 was 10"̂  ̂for the unheated material with an 
average of 1 0 *̂ “ for the heated material. However, the 
specific activity of the heated material was 3.5-fold higher 
than the specific activity of the unheated material (Table 
2).
The heat treatment of our extract at 60*C is a valid 
addition to our purification scheme for two reasons: .
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Table 1: Titration of Tobacco Mosaic Virus (TMV)
TMV purified from infected tobacco leaves by density 
gradient centrifugation was diluted in buffer pH 7.0 in a 
serial 5-^foXd dilution scheme ranging from 1:5 to 1:78,125. 
Each dilution was mixed 1:1 with buffer pH 7.0, abrasive 
added, and inoculated at 200 fil per half-leaf. The 
inoculated plants were grown for an additional 7 days, the 
leaves harvested, and the lesions counted with the aid of a 
dissecting microscope. The dilution of 1:3125 was the 
dilution found to give a countable number of lesions per 
half-leaf and was used as the standard virus dilution in 
subsequent experiments.
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1 Dilution of Virus {[ Mean* I 1 95% CL*
1:125 TNTC* —
1 1:625 541.3 426 to 656 1
*1:3125 236.6 1183 to 290
1:15625 49.9 38 to 61
1-------- 1£78125------ 8.9 5 to 13
Table 1: Titration of TMV
'The number shown is an average of the lesion counts 
obtained from 8  half-leaves.
^95% confidence limits for each sample were calculated from 
the individual lesion counts for each half-leaf.
*Too Numerous To Count
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Table 2: Heat Treatment of Datura Extract
Datura extract was heated to 6 0 for 10 minutes, cooled on 
ice for 5 minutes, and centrifuged at 12,500 x g (14-15,000 
rpm) to remove any heat-aggregated material. The samples 
were tested for antiviral activity by mixing serial 1 0 -fold 
dilutions ( 1 0  * to 1 0 )̂ of the heated and unheated material 
with the standard virus dilution and inoculating onto pinto 
bean half-leaves as previously described. In both of these 
replicates there is a 3.5-fold increase in the specific 
activity with heat treatment with a -56% recovery of 
protein.
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1 Sample* 1 xc«- 1 o/ml* mg/ml of protein^
1 Specific 
1 activity^
Expm I D 6 I^q .2.45 281.8 0.37 ■759.SU/mg
HD 6 10*2-75 562.3 0 . 2 1 2G99.2U/mg
Expm II D 6 10-2-7 501.2 0.37 1350.6U/mg
1 ______ HD 6 1 0 ^ 1 0 0 0 . 0 0 . 2 1 4800.0U/mg
Table 2: Heat Treatment of Datura Extract
ÎCso unit is defined as the dilution of the extract which 
inhibits 50% of lesion formation as compared to control.
^V/ml is the IC5 0 units contained per ml of extract.
%g/ml of protein was determined by Coomassie Brilliant Blue 
Protein assay.
^Specific activity is calculated by dividing the U/ml by 
mg/ml to determine the IC5 0 units present per mg of total 
protein.
^Abbreviations: D 6 : Unheated Datura, Preparation # 6
HD6 : Heated Datura, Preparation # 6
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1) About 50% of the protein present was precipitated, and 2) 
The specific activity of the material increased 
considerably. The increase in specific activity may be due 
to heat-inactivation or precipitation of interfering 
compounds, or dissociation of these interfering substances 
from the active material. This final option may suggest a 
method in which the material is kept in its inactive form in 
vivo until conditions are met which result in the unmasking 
of the active material.
Molecular Filtration
Several filters with different nominal molecular weight 
cutoffs (lOOK, 3OK, and lOK) were used to fractionate the 
heat-treated extract. This was done to determine the size 
(range of MW) of the active material in its native form.
The highest antiviral activity was observed in the +3 OK and 
+100K fractions (Table 3).
Âpablaza and Bernier used molecular filters to 
separate components in an extract of Datura (10). They 
found that the antiviral activity was confined to the high 
molecular weight (+50,000 MW) fraction only. The data 
obtained in this study indicate that the activity was 
present in the +100,000, +30,000, and +10,000 molecular 
weight fractions. These results are consistent with Zipf's 
statement that there may be more than one inhibitory protein
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Table 3 : Antiviral Activity of Molecular Filtration
Fractions
The fractionation of heated Datura extract through molecular 
weight cut-off filters generated four fractions. These 
fractions were tested for antiviral activity in the 
inhibition assay as previously described. The +100K 
fraction contains material which was retained by the lOOKda 
cut-off filter, the +30K fraction contains material retained 
by the 30Kda filter but not the lOOKda filter, the +10K 
fraction contains the material retained by the lOKda filter 
but not the 30Kda filter, and the -lOK fraction contains the 
material which passed through the lOKda filter. The +100K, 
+3OK, and + 1 0 K fractions are all antiviral, while the -lOK 
fraction is not.
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Sample |I Mean* |1 95% CL^ % Inhibition
Control 237.3 155 to 319 NA*
+100K 4.0 1 to 7 98.3%
+3 OK 0 . 0 0 1 0 0 .0 % 1
+10K 125.7 51 to 201 47.0%
-lOK 254.0 204 to 304 -7.0%
Table 3: Antiviral Activity of Molecular Filtration 
Fractions
^The number shown is an average lesion count of 4 half** 
leaves for experimental samples and 8  half-leaves for the 
control.
^95% confidence limits for each sample were calculated from 
the individual lesion counts for each half-leaf.
*Not applicable
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present in an extract from Datura (11). The presence of 
more than one active fraction has been observed for the 
extracts of geranium (Pelargonium hortorum B.) and pepper 
(Capsicum fmtescens L. ) where both high and low molecular 
weight components are active (1 0 ).
SDS-PAGE Of Molecular Filtration Fractions
SDS-PAGE of these fractions show that the +100K, +3OK, 
and -lOK fractions have many proteins in common. The +10K
fraction shows no protein bands in our gel. The only major
difference observed between the +100K, +3OK, and -lOK
fractions is the absence of the 17,000 MW in the -lOK
fraction (Figure 1) . This -lOK fraction also has no 
inhibitory activity.
The absence of protein bands in our + 1 0 K fraction and 
presence of protein (evaluated by BCA protein assay), 
suggest that either the protein is not staining or that the 
active protein is of a molecular weight less that 12.5K 
(smallest marker present on the gel)• The latter is the 
most probable explanation since other proteinaceous 
antivirals have been shown to be of a low molecular weight, 
i.e. meliacin (5000 to 6000 MW from Melia azedarach) and 
several di- and tri-peptide carbobenzoxy derivatives of 
phenylalanine (8 )•
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Figure 1: SD8-PA6E of Molecular Filtration Fractions
This is a 12.5% denaturing gel of the fractions obtained 
from the molecular weight fractionation of heated Datura 
extract. 1 0 0  m 1  of each fraction was mixed with 1 0 0  Ail of 
2X Laemmli Sample Buffer, boiled for 5 minutes, and 
electrophoresed as previously described. The gel was silver 
stained to visualize the protein bands.
37
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12.5K
Figure 1: SDS-PAGE of Molecular Filtration Fractions
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RMase Activity of Molecular Filtration Fractions
The samples obtained from the molecular filtration were 
tested for RNase activity as previously described# The 
stained gel showed that of the four fractions, the +100K and 
+3OK had RNase activity while the + 1 0 K and the -lOK 
fractions exhibited no RNase activity (Figure 2).
Column Chromatography:
DEAE-cellulose: Fractionation through a DEAK-cellulose
column was accomplished by a modification of the method used 
by Grasso and Shepherd (9) # The material was loaded onto 
the column which was then washed with buffer# Adsorbed 
material was eluted from the column with a linear 0-1.4M 
NaCl gradient# The absorbance at 280 nm of the fractions 
collected from the column were monitored with a 
spectrophotometer to generate a column elution profile 
(Figure 3). Fractions were pooled and tested for antiviral 
activity in the inhibition assay# Results showed that the 
antiviral activity of the extract was confined to the 
unadsorbed material and the gradient-eluted material was 
largely non-inhibitory (Table 4)# Due to these data, the 
gradient elution step was omitted in subsequent DEAE- 
cellulose chromatography of the extract, and only the 
unadsorbed material was collected for further testing 
(Figure 4)#
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Figure 2: RNase Activity of MW Fractions
Twenty-five /il of molecular weight fractions (+100K, +3OK, 
+10K, and -lOK), heated Datura extract (HD6 ), and buffer pH
7.9 (TMV), were mixed with 25 /il of TMV and H^O to 100 /il. 
These samples were incubated on ice for 30 minutes, and 2 /il 
of 10% SDS was added to disrupt the virus. 20 /il of loading 
dye was added to each sample and 40-60 /il of each was 
electrophoresed on a 1% agarose gel at 10OV to completion. 
The gel was washed with %0, stained with ethidium bromide, 
and destained with H Ô. The bands were visualized with the 
aid of a UV transilluminator. The +100K, +3OK, and heated 
Datura extract exhibit RNase activity, while the +10K and - 
lOK fractions do not.
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Figure 2: RNase Activity of MW Fractions
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Figure 3 : Elution Profile of DEAE-cellulose
Heat-treated Daturet extract was subjected to ion-exchange 
chromatography on DEAE-cellulose resin. The column was 
washed with buffer pH 7.9 and then eluted with a linear 0- 
1.4M NaCl gradient to elute any adsorbed material. 
Absorbance at 290 nm was used to generate the column 
profile. Two peaks were obtained, A and C. A contains the 
wash-through peak and C contains the gradient-eluted 
material. Each fraction is -5 ml.
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Figure 3; Elution Profile of DEIAE^Cellulose
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Table 4: Amtiviral Activity of OBAS-eallulose Column
Fractiona
Aliquots (0.1 ml) of each fraction in A-D were pooled and 
tested for antiviral activity in the inhibition assay. Pool 
A encompassing fractions 1-24 was found to contain the 
antiviral activity, while the rest of the pools had no 
activity. The material in pools B-D appear to exert a 
stimulatory action on the virus which could indicate the 
presence of some compound in the extract which could 
function as a stimulator of virus activity.
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1 Sample | Mean* |1 95% CL' 11 % Inhibition
1 Control 46.6 37 to 56 NA*
[ A (1-24) 24.0 13 to 34 48 %
B (25-53) 129.1 99 to 159 -177.1%
C (54-71) 78.5 35 to 122 -68.5%
D (72-83) 61.5 46 to 70 -31.9%
Table 4: Antiviral Activity of DEAE-cellulose Column 
Fractions
^The number shown is an average lesion count of 8  half­
leaves for experimental samples and 16 half-leaves for the 
control.
^95% confidence limits for each sample were calculated from 
the individual lesion counts for each half-leaf.
*Not applicable
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Figure 4: DBAE-celiulose Wash-through
In subsequent column purifications, the gradient elution was 
not done, and only the wash-through was collected for 
further testing. This figure shows the elution profile of 
the wash-through peak from the DEAE-cellulose column 
generated from the Â gq values of the fractions.
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Figure 4: D E Æ —Cellulose Wash— through
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Fractionation through a DEAE-cellulose column allowed for 
the removal of about 50% of the protein present in the heat- 
treated extract, with one major peak of activity present in 
the wash-through. Since DEAE-cellulose is an anion 
exchanger and binds positively-charged side groups or 
proteins, the data led us to believe that the active 
material has an overall negative or neutral charge.
CM^CBllulose; A CM-celXulose column was used to fractionate 
the concentrated, buffer^-exchanged material obtained from 
the DEAE-cellulose column wash-through. This material was 
loaded onto the column, washed with buffer until the Â gg had 
returned to background, and the adsorbed material eluted 
with a linear 0-lM NaCl gradient. The absorbance at 280 nm 
of each fraction was used generate a column elution profile 
for the CM-cellulose column (Figure 5) . Seventy-six 5 ml 
fractions were collected.
Aliquots (0.1 ml) of each fraction were pooled to 
generate four distinct pools; A (fractions 1-30), B 
(fractions 31-45), C (fractions 46-60), and, D (fractions 
61-76). These pools were tested for antiviral activity in 
the inhibition assay, and pools B (31-45) and D (61-76) 
contained the majority of the activity (Table 5)• The data 
suggest that the use of CM-cellulose (cation exchanger, 
binds negatively charged material) to fractionate the
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Figure 5: Elution Profile of CM-cellulose Column 
The wash-through peak from the DEAE-cellulose column was 
concentrated and loaded onto a CM-cellulose ion-exchange 
column. The column was washed with buffer pH 6.0 and 5 ml 
fractions were collected. This elution profile was 
generated from the Aggo values of the fractions.
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Table 5: Antiviral Activity of CM-cellulose Fraction Pools
The 0.1 ml aliquots of the material obtained from the CM- 
cellulose were pooled (Pools A-D) and tested for antiviral 
activity in the inhibition assay. Pools & and D were 
antiviral in experiment I. Pools B and D were desalted and 
tested for antiviral activity in experiment II, where 
neither was antiviral.
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Sample Mean* |1 95% Cl? 11 % Inhibition
I Control 209.0 177 to 241 NA*
A (1-30) 139.5 115 to 164 33.3%
B (31-45) 88.3 62 to 115 57.8%
C (46-60) 179.5 122 to 237 14.1%
1 D (61-76) 20.5 14 to 27 90.2%
II Control 103.1 92 to 114 NA
B (31-45) 
No Salt
161.1 128 to 194 -56.3%
D (61-76) 
No Salt
156.8 134 to 179 -52.1%
Table 5: Antiviral Activity of CM-cellulose Fraction Pools
^The number shown is an average lesion count of 8  half­
leaves for experimental samples and 16 half-leaves for the 
control.
^95% confidence limits for each sample were calculated from 
the individual lesion counts for each half-leaf.
r and II are two different experiments. The values shown 
are calculated with respect to the internal control of each 
experiment.
♦Not applicable
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active material recovered from the DEAE-cellulose column 
resulted in the active material binding to the column.
Pools B and D were desalted and buffer-exchanged to 
remove the NaCl present in solution from the gradient 
elution. The desalted pools were tested for antiviral 
activity, and neither pool B or D were antiviral (Table 5) . 
This loss of antiviral activity could be attributed to one 
or all of the following: 1> Proteins may undergo
conformational changes in binding to ion-exchangers (32), 
which could cause the adsorbed protein to be stripped of 
cofactors necessary for its activity. 2) The salt
concentration of the fractions was sufficiently high to have 
caused the precipitation or dénaturât ion of the virus 
present. 3) The salt concentration of the fractions was 
sufficiently high to have caused the precipitation or 
dénaturation of the active material. 4) The salt 
concentration of the fractions was sufficiently high to 
interfere with the pinto beans (buffer containing 0.5M NaCl 
mixed with the standard virus dilution and inoculated onto 
pinto beans caused the leaves to die). 5) The active
material may be tightly bound to the column matrix and was 
not eluted under the conditions used.
Seph^dex G-200: Due to this loss of activity, fractionation
by a G-200 Sephadex column was substituted for the CM- 
cellulose column. G-200 Sephadex fractionates proteins on
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the basis of size, with little chance that necessary 
cofactors would be stripped from the active material.
The unadsorbed material from the DEAE-cellulose column 
was concentrated and loaded onto the Sephadex column. The 
column was washed with three column-volumes of buffer and 
the absorbance of the collected fractions was used to 
generate a column elution profile (Figure 6 )• Aliquots of 
the eluted fractions were pooled for testing in the 
inhibition assay (pools A-F). Antiviral activity was 
present in pools A and B which corresponded to the void 
volume (tubes 1-5) and the major peak (tubes 6-14) of the 
column respectively (Table 6 ) . Each of the individual 
fractions encompassing pools A and B were then tested in the 
inhibitor assay, and fractions 4-11 contained the majority 
of the antiviral activity (Table 7 and Figure 7).
SD8-PA6E of Column Fractions
TCA-precipitated G-200 column fractions 4-11 were 
electrophoresed on a 12.5% SDS-PAGE gel. Upon silver 
staining, all fractions were found to contain a band of 
-17,000 MW with fractions 4 and 7-11 containing the majority 
of this material. Grasso and Shepherd also found a protein 
of -17,000 which they believed was the active material 
present in their extract from Datura (9) . Fractions 8-11 
also contained a band of -12,000 MW (Figure 8 ).
Using G-75 Sephadex for his separation, Zipf
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Figure 6: Sephadex G-200 Elution profile
The wash-torough peak from the DEAE-cellulose column was 
concentrated and loaded onto a Sephadex G-200 size-exclusion 
column. The column was washed with buffer pH 7.9 and 5 ml 
fractions were collected. This elution profile was 
generated from the values of the fractions.
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Figure 6: Sephadex G-200 Elution Profile
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Table 6; Antiviral Activity of G-200 Sephadex Fractions 
(Pooled)
The 0.1 ml alic[Uots of the material obtained from the G-200 
Sephadex column were pooled (Pools A-F) and tested for 
antiviral activity in the inhibition assay. Pools A and B 
were found to contain the antiviral activity, while pools C- 
F showed stimulatory activity
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Sample |1 Mean' 95% CL* % Inhibition |
Control 80.3 58 to 102 »»• i
A (1-5) 29.8 19 to 40 62.9% 1
B (6-14) 1.9 1 to 3 97.6%
C (15-18) 126.3 107 to 145 -57.2%
D (19-24) 132.0 1 0 2  to 162 -64.4%
E (25-30) 147.1 113 to 181 -83.2%
F (31-36) 189.9 156 to 224 -136.5%
Table 6 : Antiviral Activity of G-200 Sephadex Fractions 
{Pooled)
*The number shown is an average lesion count of 8  half­
leaves for experimental samples and 16 half-leaves for the 
control.
^95% confidence limits for each sample were calculated from 
the individual lesion counts for each half-leaf.
*Not applicable
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Table 7: Antiviral Activity of Individual G-200 Sephadex
Column Fractions
Each individual fraction encompassing pool A and B was 
individually tested for antiviral activity in the inhibition 
assay. Fractions 1-14 were tested, and fractions 4-11 were 
found to contain the majority of the antiviral activity 
observed. The peak of antiviral activity was observed at 
fraction 8 , while the absorbance peak was in fraction 1 0 .
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Sample ]I Mean' 1 95% CL* 11 % Inhibition
Control 78.0 53 to 103 NA
Fraction 1 213.4 141 to 285 -173.6%
Fraction 2 129.0 101 to 157 -65.4%
II Fraction 3 137.3 64 to 211 -76.0%
1 Fraction 4 23.3 20 to 27 70.2%
Fraction 5 1 1 . 0 1  to 2 1 85.9%
Fraction 6 7.75 5 to 11 90.1%
Fraction 7 4.5 2  to 8 94.2%
Fraction 8 0 . 8 0  to 2 98.9%
Fraction 9 1 . 0 0  to 2 98.7%
Fraction 10 2*25 0 to 5 97.1%
Fraction 11 13.0 2 to 24 83.3%
Fraction 1 2 48.8 23 to 75 37.5%
Fraction 13 36.8 21 to 53 52.9%
Fraction 14 127.3 85 to 170 -63.1%
Table 7: Antiviral Activity of Individual G - 2 0 0  Sephadex 
Column Fractions
'The number shown is an average lesion count of 4 half­
leaves for experimental samples and 8  ha If-leaves for the 
control.
*95% confidence limits for each sample were calculated from 
the individual lesion counts for each half-leaf.
*Not applicable
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Figure 7: Antiviral Activity of Column Fractions 4-11
The inhibition data obtained by testing the individual G-200 
fractions is shown super imposed on the elution profile of 
the G-200 Sephadex column. Fraction 8  contains the maximal 
antiviral activity, while the absorbance peak is seen in 
fraction 1 0  which is slightly less active.
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Figure 7: Antiviral Activity of Column Fractions 4— 11
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Figure 8 : SDS-PAGE Of 6-200 Column Fractions
One-half ml of each G-200 column fraction was TCA- 
precipitated and resuspended in 60 Ml of 2X Laemmli Sample 
Buffer for electrophoresis on a 12*5% SDS-PAGE gel. The 
resultant gel was silver stained to visualize the bands.
All samples contain a -17,000 MW band in common which is 
faintly visible in fractions 5 and 6 , and is easily seen in 
all other fractions.
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Figure 8: SDS-PAGE of G -2 0 0  Colum n F raction s
64
fractionated his extract and upon electrophoresis of this 
material found no evidence of a 17,000 MW protein (11).
This may be due to the fact that Zipf^s gels were stained 
with coomassie blue instead of silver. Gels which I stained 
with coomassie blue showed very little of this protein, but 
by using the silver stain this protein was readily visible. 
The large volwnes of eluate obtained by Zipf's G-75 
fractionation of the extract may have diluted the material 
present to a point too dilute to visualize without 
concentration.
RMase activity in Agarose Gels
TMV was incubated with the G-200 column fractions 4-11 
to determine whether the antiviral activity of the column 
fractions was associated with RNase activity. Upon gel 
electrophoresis. Fractions 4-8 were found to degrade the TMV 
RNA, with the major activity observed in fractions 4-7. 
Fractions 9-11 had little or no RNase activity (Figure 9).
Inhibition of RNase Activity
The column fractions were treated with EDTA or RNasin 
before mixing them with TMV to see if the RNase activity 
could be inhibited. After incubation, the samples were 
electrophoresed on an agarose gel and stained with ethidium 
bromide. Treatment with RNasin (Figure 10) or EDTA (Figure 
11) had no effect on RNase activity.
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Figure 9: RNase Activity of Column Fractions
Twenty-five til of column fractions 4-11 (F4-F11), heated 
Datura extract (HD6) , and buffer pH 7.9 ("MV) ̂ were mixed 
with 25 fil of TMV and H^O to 100 These samples were
incubated on ice for 30 minutes, and 2 /il of 10% SDS was 
added to disrupt the virus. Twenty til of loading dye was 
added to each sample and 40-60 til of each was 
electrophoresed on a 1% agarose gel at lOOV to completion. 
The gel was washed with H2O, stained with ethidium bromide, 
and destained with H2O. The bands were visualized with the 
aid of a UV transilluminator. Fractions 4-7 and Datura 
extract degraded TMV RNA, while fractions 9^11 showed little 
or no RNase activity. Fraction 8 exhibits some RNase 
activity.
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Figure 9: RNase A ctivity  of Column F raction s
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Figure 10: RNasin Treatment of Column Fractions
Twenty-five f&l of column fractions 4-11 (F4-F11) and heated 
Datura extract (HD6) were treated with 2 Ml of RNasin and 
incubated on ice for 30 minutes. Twenty-five Ml of TMV and 
Kfl to 100 Ml were added and incubated on ice for an 
additional 30 minutes. Two Ml of 10% SDS was added to 
disrupt the virus. Twenty m1 of loading dye was added to 
each sample and 40-60 Ml of each was electrophoresed on a 1% 
agarose gel at lOOV to completion. The gel was washed with 
HjO, stained with ethidium bromide, and destained with HjO. 
The bands were visualized with the aid of a UV 
transilluminator. Treatment with the RNasin had little or 
no effect on the RNase activity of the fractions.
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Figure 10: RNasin T reatm ent of Colum n F raction s
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Figure XI: EDTA Treatment of Column Fractions
Twenty-five til of column fractions 4-11 (F4-F11) and heated 
Datura extract (HD6> were treated with 2 /xi of 0.5M EDTA and 
incubated on ice for 30 minutes. Twenty-five /xl of TMV and 
H2O to 100 /xl were added and incubated on ice for an 
additional 30 minutes. Two /xl of 10% SDS was added to 
disrupt the virus. Twenty /xl of loading dye was added to 
each sample and 40-60 /xl of each was electrophoresed on a 1% 
agarose gel at lOOV to completion. The gel was washed with 
HjO, stained with ethidium bromide, and destained with HgO. 
The bands were visualized with the aid of a UV 
transilluminator. Treatment with the EDTA had little or no 
effect on the RNase activity of the fractions.
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The fact that RNase is not inhibited by the presence of EDTA 
suggests that this RNase activity is not dependent on the 
presence of divalent cations, a result which agrees with 
results obtained by Zipf (11). RNasin treatment of the 
fractions also showed no inhibition of activity. RNasin 
functions by binding to the active site of some RNases and 
blocking their activity (personal communication).
Protease Treatment of Column Fractions
The antiviral activity of the undigested G-^200 
fractions was unaffected by incubating for 24 hours at 37 
with the exception of fraction 7. Treatment of the column 
fractions with trypsin conjugated to acrylic beads destroyed 
the antiviral activity of the fractions as compared to the 
controls (Table 8).
Native Molecular Weight
Markers of known molecular weights were eluted from the 
G-200 column and a calibration curve was generated by 
plotting the Ve/Vo (elution volume of the marker/elution 
volume of the blue dextran) of each marker against its' 
molecular weight (Figure 12). Comparison of the Ve/Vo for 
column fractions 4-11 to the calibration curve gave a 
molecular weight range for the proteins present in the 
column fractions (Table 9). Since the material eluted from 
the column was present as one peak, an assumption could be
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Table 8: Trypsin Treatment of Column Fractions
Two 600 111 aliquots of each fraction were thawed and one 
aliquot of each was treated with 20 mg of trypsin conjugated 
to acrylic beads. Two 600 /xl aliquots of buffer were also 
prepared, one aliquot treated with 20 mg of enzyme and the 
other untreated. All samples were incubated at 37"C for 24 
hours with shaking. The samples were centrifuged at 12,500 
X g for 1  minute to precipitate the beads or any heat- 
aggregated material, and the supernatants collected for 
testing in the inhibition assay as previously described.
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Sample |1 Mean' 95% Cl/ 11 %Inhibition^
Control 46.1 36 to 56 NA*
Buffer 61.3 9 to 113 NA*
Buffer+T 152.0 0 to 324 NA*
1 Fraction 7 133.0 74 to 192 -177.1%
1 Fraction 8 18.3 15 to 21 70.2%
\ Fraction 9 14.3 11 to 17 76.7%
II Fraction 10 7.8 0 to 16 87.4%
Fraction 11 11.3 0 to 31 75.6%
Fraction 12 112.8 68 to 158 -84.1%
Fraction 7T 56.3 31 to 81 62.9%
Fraction 8T 136.0 51 to 221 10.5%
Fraction 9T 177.3 128 to 226 -16.6%
Fraction lOT 168.8 111 to 226 -11.0%
Fraction IIT 164.5 114 to 215 -8.2%
Fraction 12T 185.3 63 to 308 -21.9%
Table 8: Trypsin Treatment of Column Fractions
'The value given is an average lesion count of 8 half-leaves 
for the control and 4 half-leaves for each experimental.
^95% confidence limits for each sample were calculated from 
the individual lesion counts for each half-leaf•95% CL^
^he % inhibition for the experimental samples have been 
determined by comparison with internal controls. The 
samples not treated with the enzyme are calculated with 
respect to the buffer sample. The enzyme-treated samples 
are calculated with respect to the enzyme-treated buffer sample.
Note: The T designation denotes treatment with trypsin for 
24 hours at 37*0 with shaking.
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Figure 12: G-200 Calibration Curve
Markers of a known molecular weight were loaded onto the G- 
200 Sephadek column and eluted with buffer pH 7.9, 
collecting 1 ml fractions. The calibration curve was 
generated by plotting the molecular weight of each marker 
against its' Vg/V@ (marker elution volume/elution volume of 
Blue Dextran) . The molecular weight of each unknown 
fraction was determined by calculating the V^/V© for each and 
using this value to extrapolate the approximate molecular 
weight from this curve.
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Table 9: Calibration of the Sephadex 6 - 2 0 0  Column and
Determination of Native Molecular Weight
The known molecular weight and the elution volume of each 
marker was used to generate Figure 12. The V^/Vq calculated 
for 6*200 fractions 4*11 were used to extrapolate to a range 
of approximate molecular weights possible for the protein 
complex present in each fraction.
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Sample | Ve* II Ve/Vo^ 1r Approx. MW^
Blue Dextran 19.44 ml 
(VOID VOLUME)
1.00 2 9 0 0 0 , 0 0 0
B-Amylase 25.11 ml 1.29 200,000
Alcohol
Dehydrogenase
29.16 ml 1.50 150,000
BSA 30.78 ml 1.58 66,000
Carbonic
Anhydrase
44.55 ml 2.29 29,000
Cytochrome C 49.41 ml 2.54 12,400
Fraction 4 
(VOID VOLUME)
20-25 ml 1.02-1.29 +320,000
Fraction S 25—30 ml 1.29-1.54 320,000-
180,000
Fraction 6 30—35 ml 1.54-1.80 180,000-120,000
Fraction 7 35—40 ml 1.80-2.05 120,000-65,000
Fraction 8 40—45 ml 2.05-2.31 65,000-42,000
Fraction 9 45—50 ml 2.31-2.57 42,000-23,000
Fraction 10 50-55 ml 2.57-2.83 23,000-13,000
Fraction 11 55—60 ml 2.83-3.08 13,000-7,000
Table 9: Calibration of the Sephadex G-200 Column andDetermination of Native Molecular Weight
'Values given are the elution volumes of each marker or 
fraction.
^Values given are Ve divided by the Ve of Blue Dextran (Vo 
for the column)
^All molecular weights given are approximate. The MW of the 
markers are given in the GF-3 bulletin supplied in the MW- 
GF-200 kit from Sigma. The molecular weights of the column 
fractions are extrapolated from the calibration curve.
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made that the material eluted is present as a complex. This 
would imply that the native molecular weight of the complex 
is an average of the values obtained, or *87,000 MW.
DISCUSSION
At the start of this project, the main goal was to 
isolate and purify to molecular homogeneity the antiviral 
protein from our extract. Upon obtaining a protein which 
was homogenous, the second goal of the project was to 
characterize this protein. This project was based partly on 
work done previously by Zipf (11). Data obtained in the 
study by Zipf suggested that there was probably only one 
antiviral factor present in the extract of Datura. This 
antiviral factor was proteinaceous in nature, but was 
resistant to many treatments known to inactivate proteins«
The initial step in the purification of the antiviral 
from a 60-80% ammonium sulfate precipitated fraction of the 
extract was to subject this fraction to heat. Previous work 
(11) had shown that the activity of the extract was not 
affected by temperatures up to 65*0 for 10 minutes. Our 
extract was heated to 60*0 for 10 minutes, and we found that 
this heating did indeed remove about half of the protein 
content from solution. As a result, the specific activity 
of our heat-treated extract was 3-4 times that of the 
unheated material.
Fractionation of the heat-treated extract by the use of 
centrifugal filters and subsequent testing in the inhibition 
assay indicated that native molecular weight of the active 
material was greater than 30,000. These data suggest that 
the active components may be present as a complex containing
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both low and high molecular weight components, or that there 
is more than one antiviral factor present. This has been 
seen previously in other antiviral extracts (10)•
Electrophoresis under denaturing conditions shows that 
these fractions are composed of proteins ranging from 10,000 
to 100,000 mw which are present as either a complex or 
aggregate large enough to be retained by these filters. The 
sample containing proteins between 30,000 and 10,000 shows 
no visible bands but does possess antiviral activity. This 
indicates that there is either some compound which is not 
visible under our electrophoresis/staining, or the material 
is less than the resolution limit of our gel system (less 
than 10,000 mw)• The latter is possible, as other compounds 
such as small proteins, peptides, and enzymes have been 
found to be antiviral (8).
An assay testing these samples for RNase activity 
showed that the +100,000 MW and +30,000 MW samples had RNase 
activity, while the samples less than 30,000 MW did not.
This indicates that the antiviral activity observed in the 
greater than 30,000 MW fractions may be due in part to the 
activity of an RNase.
Fractionation of the heat-treated extract through the 
DEAE-cellulose and the Sephadex G-200 allowed us to further 
purify our active material. The one major peak obtained 
from the G-200 column was antiviral. Upon SDS-PAGE of the 
individual fractions obtained from this column, all the
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antiviral fractions contained a protein with a molecular 
weight of -17,000. This agrees with previous work done with 
Datura, which showed a intense double band at -17,000 MW on 
SDS-PAGE after being purified by ion-exchange chromatography 
(9). This disagrees with more recent data (11), however, 
the purification conditions in the study were much less 
stringent.
In the peak of antiviral activity from Sephadex G-200, 
there are two main areas of activity. The first -45% of the 
peak contains RNase activity and is also antiviral, while 
the remainder of the peak has only antiviral activity. The 
entire peak contains the -17,000 MW protein indicating that 
this protein is probably responsible for a portion of the 
antiviral activity. The RNase activity is confined to the 
fractions containing larger molecules which is supported by 
the molecular weight fractionation data.
The elution volumes of the G-200 column fractions were 
used to determine the approximate native molecular weight of 
the material present. Knowing that the material was eluted 
in a single peak, the molecular weight values of each 
fraction were averaged to obtain -87,000 MW as the probable 
molecular weight for the active complex.
Protease digestion of the Sephadex G-200 column 
fractions shows that the antiviral material is susceptible 
to trypsin, indicating that this material is proteinaceous 
in nature. This disagrees with previous data, which
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indicated the antiviral activity was not susceptible to 
trypsin (II).
SDS-PAGE data in conjunction with results obtained in 
the inhibition assay and RNase activity assay suggest that 
there may be at least three compounds in the extract which 
are inhibitory. Of these proteins, one or two are strictly 
antiviral (no RNase activity) and the other is inhibitory by 
virtue of its RNase activity. All these data suggest that 
the active material is present as a complex of -87,000 MW. 
This active complex contains proteins of -17,000 MW and 
-12,000 MW, an RNase active protein, and an antiviral 
protein of unknown size (probably between 10,000 and 30,000 
MW) .
FUTURE STUDIES
Due to the complex nature of this extract further work 
needs to be done to identify and characterize the individual 
compounds responsible for the observed activities.
Initially, the material present in the Sephadex G-200
peak needs to separated into individual components. This
could be accomplished by continuous electrophoretic elution 
or HPLC. This would allow each component to be tested for 
both antiviral and RNase activity, which would serve to 
identify the component(s) responsible for these actions.
It is possible that the material needs to be present as
a complex to be active. The components necessary for
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activity could be determined by adding together the isolated 
components until the activity is restored. This should also 
Indicate the stoichiometry of the components in the complex.
The RNase active molecule needs to be characterized in 
its activity and specificity (34), and an inhibitor of its 
activity found. This would allow the RNase-active portion 
to be inactivated to unmask any other activities this 
molecule may have.
The possibility that this extract could be a ribosomal 
inhibitory protein needs to be investigated. By using a 
cell-free system assay system (such as wheat-germ or rabbit 
reticulocyte lysate) and exogenously added mRNA or TMV RNA 
as the template, the activity of extract components could be 
further characterized.
The virus-stimulating activity observed in some of the 
fractions should be further investigated. Isolating and 
characterizing the compound responsible for this activity 
may provide insight into virus/inhibitor interaction.
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